Multi-Disciplined Ecosystem-Centric Bioentrepreneurship Education: Case Study – University of San Francisco (USF)
Bioentrepreneurship education has evolved into at least three different types, all of which co-exist: Education 1.0 - In Service of Biotechnology Startups, Education 2.0 – In Service of Biotechnology Innovation Ecosystems, and Education 3.0 – In Collaboration with Biotechnology Innovation Ecosystems. Examples are given at all levels, along with a Case Study of the Bioentrepreneurship (BioE) program at the University of San Francisco (USF). The USF program draws from twelve expertise disciplines described by the Bioenterprise Innovation Expertise Model (BIEM 2.0), those essential disciplines bioenterprise requires to bridge the science/technology discovery/invention through to viable commercial product life cycle. As a result, the USF program reaches graduate students across the university. The utilization of the BIEM 2.0 model throughout the BioE courses is discussed, as well as the incorporation into the curriculum of BioTech Nation interviews with biotechnology industry executives and scientists. Due to the COVID-19 Pandemic and the requirement to move the BioE courses to a remote modality, future plans include the development of a fully online Bioentrepreneurship (BioE) certificate, primarily targeting the California state biotechnology corridor of San Francisco, Los Angeles, Orange County, and San Diego Biotechnology Innovation Ecosystems. Additional new BioE courseware will address the growing sector of Digital Health.
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).